Answers are grounded in this paper and cite their sources.
Few instances of treatment-emergent resistance to bictegravir have been reported in the literature. We describe a case of treatment-emergent resistance to bictegravir in a person recently diagnosed with human immunodeficiency virus who developed M184V and R263K mutations while on therapy.
No takes yet. Share an insight, caveat, or question.
Chamberlain et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: